|
Systemic Lupus Erythematosus and Autoimmunity
Citations 311-320 of 461 total displayed.
|
Past content
(since Jan 2000):
|
- BASIC SCIENCE
Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response
- H. Schotte, M. Gaubitz, P. Willeke, N. Tidow, G. Assmann, W. Domschke, and B. Schlüter
Rheumatology 2004; 43: 1357-1363.
[Abstract]
[Full Text]
- CLINICAL
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative
- C. E. Lampropoulos, S. Sangle, P. Harrison, G. R. V. Hughes, and D. P. D'Cruz
Rheumatology 2004; 43: 1383-1385.
[Abstract]
[Full Text]
[ Supplementary data ]
- CLINICAL
Factors associated with abnormal Pap results in systemic lupus erythematosus
- S. Bernatsky, R. Ramsey-Goldman, C. Gordon, L. Joseph, J.-F. Boivin, R. Rajan, A. Allen, A. D. Moore, M.-H. Leung, and A. Clarke
Rheumatology 2004; 43: 1386-1389.
[Abstract]
[Full Text]
- CLINICAL
Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus
- M. C. A. Polderman, S. le Cessie, T. W. J. Huizinga, and S. Pavel
Rheumatology 2004; 43: 1402-1404.
[Abstract]
[Full Text]
- CLINICAL
Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome
- E. Drewe, M. L. Huggins, A. G. Morgan, M. J. D. Cassidy, and R. J. Powell
Rheumatology 2004; 43: 1405-1408.
[Abstract]
[Full Text]
- CASE REPORTS
A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion
- C. P. Mavragani, P. G. Vlachoyiannopoulos, N. Kosmas, I. Boletis, A. G. Tzioufas, and M. Voulgarelis
Rheumatology 2004; 43: 1450-1451.
[Extract]
[Full Text]
- CASE REPORTS
Recurrent multifocal Mycobacterium kansasii infection in an immunosuppressed patient with myelodysplasia and relapsing polychondritis
- N. Benton, S. Musaad, R. Vaughan, and L. McLean
Rheumatology 2004; 43: 1453-1454.
[Extract]
[Full Text]
- CLINICAL
A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus
- H. Ida, E. Kawasaki, T. Miyashita, F. Tanaka, M. Kamachi, Y. Izumi, M. Huang, M. Tamai, T. Origuchi, A. Kawakami, K. Migita, M. Motomura, T. Yoshimura, and K. Eguchi
Rheumatology 2004; 43: 1292-1299.
[Abstract]
[Full Text]
- CLINICAL
Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus
- S. Bernatsky, A. Clarke, R. Ramsey-Goldman, L. Joseph, J.-F. Boivin, R. Rajan, A. D. Moore, M.-H. Leung, A. Allen, and C. Gordon
Rheumatology 2004; 43: 1178-1181.
[Abstract]
[Full Text]
- CLINICAL
The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus
- S. D. Marks, C. Pilkington, P. Woo, and M. J. Dillon
Rheumatology 2004; 43: 1186-1189.
[Abstract]
[Full Text]
|
|
